Cytovance Biologics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 243

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Cytovance Biologics General Information

Description

Developer and manufacturer of bio-pharmaceutical products intended to offer innovative development and clinical or commercial manufacturing of large molecule APIs from mammalian cell culture, microbial fermentation and plasmid DNA. The company provides therapeutic proteins and antibodies, cell culture development, purification development, troubleshooting existing processes and analytical development support services as well as cell banking, microbial, mammalian and support services, thereby providing clients with microbial and mammalian expression systems to support scale-up at every stage.

Contact Information

Formerly Known As
Cytovance Inc
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 800 Research Parkway
  • Suite 200
  • Oklahoma City, OK 73104
  • United States
+1 (405)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Corporate Office
  • 800 Research Parkway
  • Suite 200
  • Oklahoma City, OK 73104
  • United States
+1 (405)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytovance Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cytovance Biologics‘s full profile, request access.

Request a free trial

Cytovance Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of bio-pharmaceutical products intended to offer innovative development and clinical or comme
Biotechnology
Oklahoma City, OK
243 As of 2023

Irvine, CA
 

Shanghai, China
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytovance Biologics Competitors (38)

One of Cytovance Biologics’s 38 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneTex Formerly VC-backed Irvine, CA
EpimAb Biotherapeutics Venture Capital-Backed Shanghai, China
ProMab Biotechnologies Corporate Backed or Acquired Richmond, CA
BeiGene Formerly PE-Backed Beijing, China
BioLegend Formerly Accelerator/Incubator backed San Diego, CA
You’re viewing 5 of 38 competitors. Get the full list »

Cytovance Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytovance Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cytovance Biologics‘s full profile, request access.

Request a free trial

Cytovance Biologics FAQs

  • When was Cytovance Biologics founded?

    Cytovance Biologics was founded in 2003.

  • Where is Cytovance Biologics headquartered?

    Cytovance Biologics is headquartered in Oklahoma City, OK.

  • What is the size of Cytovance Biologics?

    Cytovance Biologics has 243 total employees.

  • What industry is Cytovance Biologics in?

    Cytovance Biologics’s primary industry is Biotechnology.

  • Is Cytovance Biologics a private or public company?

    Cytovance Biologics is a Private company.

  • What is the current valuation of Cytovance Biologics?

    The current valuation of Cytovance Biologics is .

  • What is Cytovance Biologics’s current revenue?

    The current revenue for Cytovance Biologics is .

  • How much funding has Cytovance Biologics raised over time?

    Cytovance Biologics has raised $44M.

  • Who are Cytovance Biologics’s investors?

    Great Point Partners, Presbyterian Health Foundation, and i2E have invested in Cytovance Biologics.

  • Who are Cytovance Biologics’s competitors?

    GeneTex, EpimAb Biotherapeutics, ProMab Biotechnologies, BeiGene, and BioLegend are some of the 38 competitors of Cytovance Biologics.

  • When was Cytovance Biologics acquired?

    Cytovance Biologics was acquired on 06-Oct-2015.

  • Who acquired Cytovance Biologics?

    Cytovance Biologics was acquired by Hepalink USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »